β¨ Medicines Consent Notices
1 APRIL 2004
NEW ZEALAND GAZETTE, No. 39
979
Dated this 23rd day of March 2004.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on the 6th day of July 2001).
go2029
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Panadol Mini Caps (pharmacy only)
Active Ingredient: Paracetamol 500mg
Dosage Form: Coated tablet
New Zealand Sponsor: GlaxoSmithKline (NZ) Limited
Manufacturer: GlaxoSmithKline Australia Pty Limited, Ermington, New South Wales, Australia
Product: Panadol Mini Caps (general sale)
Active Ingredient: Paracetamol 500mg
Dosage Form: Coated tablet
New Zealand Sponsor: GlaxoSmithKline (NZ) Limited
Manufacturer: GlaxoSmithKline Australia Pty Limited, Ermington, New South Wales, Australia
Product: Resolve Jock Itch
Active Ingredient: Miconazole nitrate 2%w/w
Dosage Form: Topical cream
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturer: Ego Pharmaceuticals Pty Limited, Braeside, Victoria, Australia
Dated this 29th day of March 2004.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on the 6th day of July 2001).
go2179
Renewal of Provisional Consent to the Distribution of a New Medicine
Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: Viramune
Active Ingredient: Nevirapine hemihydrate 10.35mg/mL equivalent 10mg/mL nevirapine
Dosage Form: Oral suspension
New Zealand Sponsor: Boehringer Ingelheim (NZ) Limited
Manufacturer: Roxane Laboratories Inc, Columbus, Ohio, United States of America
Note: This consent is valid for two years from 2 March 2004.
Dated this 29th day of March 2004.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on the 6th day of July 2001).
go2180
Consent to the Distribution of Changed Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Aldara
Active Ingredient: Imiquimod 5%w/w
Dosage Form: Topical cream
New Zealand Sponsor: 3M New Zealand Limited
Manufacturer: 3M Health Care (UK) Limited, Loughborough, Leicestershire, England
Product: Avandia
Active Ingredient: Rosiglitazone maleate 5.3mg equivalent to 4mg rosiglitazone
Dosage Form: Film coated tablet
New Zealand Sponsor: GlaxoSmithKline (NZ) Limited
Manufacturer: SB Pharmaco PR Inc, Barrio Certenejas, Cidra, Puerto Rico
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2004, No 39
Gazette.govt.nz —
NZ Gazette 2004, No 39
β¨ LLM interpretation of page content
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social Welfare23 March 2004
Medicines, Consent, Distribution, Panadol Mini Caps, Resolve Jock Itch
- DON MATHESON, Deputy Director-General, Public Health
π₯ Renewal of Provisional Consent to the Distribution of a New Medicine
π₯ Health & Social Welfare29 March 2004
Medicines, Provisional Consent, Renewal, Viramune
- DON MATHESON, Deputy Director-General, Public Health
π₯ Consent to the Distribution of Changed Medicines
π₯ Health & Social Welfare29 March 2004
Medicines, Consent, Changed, Aldara, Avandia
- DON MATHESON, Deputy Director-General, Public Health